Robertson GP - Search Results

1

Drug-Tolerant Persister Cells in Cancer Therapy Resistance.

Dhanyamraju PK, Schell TD, Amin S, Robertson GP. Dhanyamraju PK, et al. Among authors: robertson gp. Cancer Res. 2022 Jul 18;82(14):2503-2514. doi: 10.1158/0008-5472.CAN-21-3844. Cancer Res. 2022. PMID: 35584245 Free PMC article. Review.

2

Loss of PTEN promotes tumor development in malignant melanoma.

Stahl JM, Cheung M, Sharma A, Trivedi NR, Shanmugam S, Robertson GP. Stahl JM, et al. Among authors: robertson gp. Cancer Res. 2003 Jun 1;63(11):2881-90. Cancer Res. 2003. PMID: 12782594

3

Deregulated Akt3 activity promotes development of malignant melanoma.

Stahl JM, Sharma A, Cheung M, Zimmerman M, Cheng JQ, Bosenberg MW, Kester M, Sandirasegarane L, Robertson GP. Stahl JM, et al. Among authors: robertson gp. Cancer Res. 2004 Oct 1;64(19):7002-10. doi: 10.1158/0008-5472.CAN-04-1399. Cancer Res. 2004. PMID: 15466193

4

Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.

Sharma A, Trivedi NR, Zimmerman MA, Tuveson DA, Smith CD, Robertson GP. Sharma A, et al. Among authors: robertson gp. Cancer Res. 2005 Mar 15;65(6):2412-21. doi: 10.1158/0008-5472.CAN-04-2423. Cancer Res. 2005. PMID: 15781657

5

Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases.

Sharma A, Tran MA, Liang S, Sharma AK, Amin S, Smith CD, Dong C, Robertson GP. Sharma A, et al. Among authors: robertson gp. Cancer Res. 2006 Aug 15;66(16):8200-9. doi: 10.1158/0008-5472.CAN-06-0809. Cancer Res. 2006. PMID: 16912199 Free PMC article.

6

PRAS40 deregulates apoptosis in malignant melanoma.

Madhunapantula SV, Sharma A, Robertson GP. Madhunapantula SV, et al. Among authors: robertson gp. Cancer Res. 2007 Apr 15;67(8):3626-36. doi: 10.1158/0008-5472.CAN-06-4234. Cancer Res. 2007. PMID: 17440074

7

Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation.

Liang S, Sharma A, Peng HH, Robertson G, Dong C. Liang S, et al. Cancer Res. 2007 Jun 15;67(12):5814-20. doi: 10.1158/0008-5472.CAN-06-4233. Cancer Res. 2007. PMID: 17575149 Free PMC article.

8

Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.

Girroir EE, Hollingshead HE, Billin AN, Willson TM, Robertson GP, Sharma AK, Amin S, Gonzalez FJ, Peters JM. Girroir EE, et al. Among authors: robertson gp. Toxicology. 2008 Jan 14;243(1-2):236-43. doi: 10.1016/j.tox.2007.10.023. Epub 2007 Nov 4. Toxicology. 2008. PMID: 18054822 Free PMC article.

9

Is B-Raf a good therapeutic target for melanoma and other malignancies?

Madhunapantula SV, Robertson GP. Madhunapantula SV, et al. Among authors: robertson gp. Cancer Res. 2008 Jan 1;68(1):5-8. doi: 10.1158/0008-5472.CAN-07-2038. Cancer Res. 2008. PMID: 18172288 Review.

10

Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

Cheung M, Sharma A, Madhunapantula SV, Robertson GP. Cheung M, et al. Among authors: robertson gp. Cancer Res. 2008 May 1;68(9):3429-39. doi: 10.1158/0008-5472.CAN-07-5867. Cancer Res. 2008. PMID: 18451171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page